Cytokine RNA expression in an equine CD4+ subset differentiated by expression of a novel 46-kDa surface protein.

[1]  W. Davis,et al.  Culture conditions that optimize outgrowth of hybridomas. , 1995, Methods in molecular biology.

[2]  W. Davis,et al.  Monoclonal antibodies to the equine CD2 T lymphocyte marker, to a pan-granulocyte/monocyte marker and to a unique pan-B lymphocyte marker. , 1994, Immunobiology.

[3]  B. Autran,et al.  An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients , 1994, European journal of immunology.

[4]  D. Horohov,et al.  Molecular cloning and sequencing of equine interleukin 4. , 1994, Veterinary immunology and immunopathology.

[5]  S. F. Schlossman,et al.  CD antigens 1993. , 1994, Journal of immunology.

[6]  F. Malavasi,et al.  Human CD38: a glycoprotein in search of a function. , 1994, Immunology today.

[7]  S. Romagnani.  Lymphokine production by human T cells in disease states. , 1994, Annual review of immunology.

[8]  D. Horohov,et al.  Molecular cloning and expression of equine interleukin 2. , 1993, Veterinary immunology and immunopathology.

[9]  M. Holmes,et al.  Equine T-lymphocyte MHC II expression: variation with age and subset. , 1993, Veterinary immunology and immunopathology.

[10]  J. Justement,et al.  CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. , 1992, Journal of immunology.

[11]  W. Davis,et al.  Identification of Anaplasma marginale long-term carrier cattle by detection of serum antibody to isolated MSP-3 , 1991, Journal of clinical microbiology.

[12]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[13]  F. Malavasi,et al.  CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. , 1990, Journal of immunology.

[14]  P. Linsley,et al.  T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  P. Linsley,et al.  Role of the CD28 receptor in T-cell activation. , 1990, Immunology today.

[16]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[17]  H. Macdonald,et al.  The Cellular Basis of T-Cell Memory , 1989 .

[18]  W. Davis,et al.  T lymphocyte development in horses. I. Characterization of monoclonal antibodies identifying three stages of T lymphocyte differentiation. , 1988, Veterinary immunology and immunopathology.

[19]  B. Seed,et al.  Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Hoffman,et al.  Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. B. Mishell,et al.  Selected Methods in Cellular Immunology , 1980 .

[22]  T. McGuire,et al.  Immunologically mediated glomerulitis of horses. I. Pathogenesis in persistent infection by equine infectious anemia virus. , 1972, Laboratory investigation; a journal of technical methods and pathology.